Molnupiravir
Not Omicron but greed of capital threatens the world

The deliberate policy of big pharma and rich countries to leave large populations in poorer countries unvaccinated could plunge the world into another downturn

Molnupiravir: A welcome development but accessibility still a question

Dr. Satyajit Rath talks about key aspects of the new drug, Molnupiravir, and points out that a lot that needs attention to make sure the drug becomes accessible to the poorer nations

Equitable access to Covid-19 diagnostics and therapeutics is key to ending the pandemic

One year has passed since the TRIPS waiver proposal was first tabled at the World Trade Organization, and rich countries persevere in opposing it. This has affected the availability of vaccines, and is having effect on access to diagnostics and therapeutics too

    × To Subscribe